Portugal, April 23 -- Portugal based ASTRAZENECA-PRODUTOS FARMACEUTICOS,LDA. has secured contract from Unidade Local De Saude Amadora/Sintra, E.P.E. for Acquisition Of Tezepellumab Sc 110Mgml 1.91Ml S Inj Can, To Lab Astrazeneca For Ulsasi, For The Year 2025. The value of the contract is worth 13665600 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....